-       Report 
- January 2025
-  185 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- October 2025
-  465 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  270 Pages 
- Global 
   From       €4468EUR$4,995USD£3,930GBP 
            -       Report 
- October 2025
-  194 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- October 2025
-  197 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
           -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- July 2023
-  200 Pages 
- Global 
   From       €4159EUR$4,650USD£3,659GBP 
          -       Report 
- October 2023
-  120 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- October 2023
-  117 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- March 2024
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
          -       Report 
- November 2021
-  527 Pages 
- Global 
   From       €3578EUR$4,000USD£3,147GBP 
         
      The miRNA Sequencing market is a subset of the larger genomics market. It is focused on the sequencing of microRNAs, which are small, non-coding RNA molecules that regulate gene expression. miRNA sequencing is used to identify and quantify miRNAs in a sample, and can be used to study gene expression, disease diagnosis, and drug development.
miRNA sequencing is a rapidly growing field, with a variety of companies offering services and products. These include Illumina, Thermo Fisher Scientific,    Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less   Read more